Letter by Kong and Wang Regarding Article, “Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial”

X Xiangpan Kong (Department of Urology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders (X.K.), Children’s Hospital of Chongqing Medical University, Chongqing, PR China.) Q Quan Wang (Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases)

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue 20
Published November 18, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (2)

X

Xiangpan Kong

Department of Urology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders (X.K.), Children’s Hospital of Chongqing Medical University, Chongqing, PR China.

Q

Quan Wang

Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases